Evidence map›Paper›PMID 24613344›Full record

ArticleMolecular cell2014

Suppression of genome instability in pRB-deficient cells by enhancement of chromosome cohesion.

Amity L Manning, Stephanie A Yazinski, Brandon Nicolay, Alysia Bryll, Lee Zou, Nicholas J Dyson

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amity L ManningMassachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA.
Stephanie A YazinskiMassachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA.
Brandon NicolayMassachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA.
Alysia BryllMassachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA.
Lee ZouMassachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA.
Nicholas J DysonMassachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA. Electronic address: dyson@helix.mgh.harvard.edu.
Harvard University · USMassachusetts General Hospital · US

Funding

Regulation of the ATR Checkpoint Kinase by DNA DamageR01GM076388 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI ZOU, LEE · 2006 to 2018
$4.3M
The Origins of Chromosomal Instability in Human Tumor CellsR01CA155202 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DYSON, NICHOLAS J · 2011 to 2015
$1.8M
Understanding the role of SKP2 in small cell lung cancer progressionF32CA165856 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI NICOLAY, BRANDON · 2012 to 2014
$149k
Manipulating chromosome structure to suppress genome instabilityK99CA182731 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MANNING, AMITY · 2014 to 2014
$135k
NCI NIH HHS CA155202NCI NIH HHS F32 CA165856NCI NIH HHS K99 CA182731NCI NIH HHS R01 CA155202NIGMS NIH HHS GM076388NIGMS NIH HHS R01 GM076388
6 · The paper itself

Abstract

Chromosome instability (CIN), a common feature of solid tumors, promotes tumor evolution and increases drug resistance during therapy. We previously demonstrated that loss of the retinoblastoma protein (pRB) tumor suppressor causes changes in centromere structure and generates CIN. However, the mechanism and significance of this change was unclear. Here, we show that defects in cohesion are key to the pRB loss phenotype. pRB loss alters H4K20 methylation, a prerequisite for efficient establishment of cohesion at centromeres. Changes in cohesin regulation are evident during S phase, where they compromise replication and increase DNA damage. Ultimately, such changes compromise mitotic fidelity following pRB loss. Remarkably, increasing cohesion suppressed all of these phenotypes and dramatically reduced CIN in cancer cells lacking functional pRB. These data explain how loss of pRB undermines genomic integrity. Given the frequent functional inactivation of pRB in cancer, conditions that increase cohesion may provide a general strategy to suppress CIN.

Indexed as

Chromosomal InstabilityGene Expression Regulation, NeoplasticCell Cycle ProteinsCell Line, TumorCell Transformation, NeoplasticCentromereChromosomal Proteins, Non-HistoneChromosome SegregationCohesinsGenome, HumanHistonesHumansMethylationRetinoblastoma ProteinRNA, Small InterferingSignal TransductionCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsHistonesRetinoblastoma ProteinRNA, Small Interfering

Identifiers

PMID24613344
PMCPMC4047977
OpenAlexW2149686649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.